marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
VistaGen Therapeutics Balance Sheet 2011-2024 | VTGN
Annual Balance Sheet VistaGen Therapeutics
| 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-117 M | -14 M | -99.4 M | 2.74 M | -13 M | -10.3 M | -2.85 M | -358 K | 14.2 M | 6.91 M | 4.7 M | 3.19 M | - | |
Long Term Debt |
1.57 M | 2.12 M | - | 3.35 M | - | - | - | - | 27.2 K | 332 K | 4.78 M | 4.62 M | 2.67 M | - |
Long Term Debt Current |
550 K | 486 K | 433 K | 365 K | 313 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 4.16 M | 12.1 M | 8.73 M | 4.14 M | 2.9 M | 1.73 M | 2.17 M | 3.42 M | 7.86 M | 11 M | 2.87 M | - |
Total Current Liabilities |
5.12 M | 4.57 M | 5.77 M | 4.19 M | 2.77 M | 2.8 M | 1.46 M | 1.37 M | 1.79 M | 17.4 M | 5.21 M | 2.41 M | 3.18 M | - |
Total Liabilities |
9.37 M | 9.01 M | 9.93 M | 16.3 M | 11.5 M | 6.94 M | 4.36 M | 3.1 M | 3.97 M | 20.8 M | 13.1 M | 13.4 M | 6.05 M | - |
Deferred Revenue |
791 K | 714 K | 1.24 M | 1.42 M | - | - | - | - | - | - | - | - | 13.2 K | - |
Retained Earnings |
-356 M | -327 M | -268 M | -220 M | -202 M | -181 M | -157 M | -142 M | -132 M | -84.5 M | - | - | -54.8 M | - |
Total Assets |
124 M | 21.1 M | 74.6 M | 108 M | 5.77 M | 14 M | 11.3 M | 3.71 M | 990 K | 270 K | 264 K | 882 K | 342 K | - |
Cash and Cash Equivalents |
119 M | 16.6 M | 68.1 M | 103 M | 1.36 M | 13.1 M | 10.4 M | 2.92 M | 428 K | 70 K | - | 638 K | 81 K | 139 K |
Book Value |
114 M | 12.1 M | 64.7 M | 92 M | -5.73 M | 7.08 M | 6.92 M | 616 K | -2.98 M | -20.5 M | -12.8 M | -12.6 M | -5.71 M | - |
Total Shareholders Equity |
114 M | 12.1 M | 64.7 M | 92 M | -5.73 M | 7.08 M | 6.92 M | 616 K | -2.98 M | -20.5 M | -12.8 M | -12.6 M | -5.71 M | -32.9 M |
All numbers in USD currency
Quarterly Balance Sheet VistaGen Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.27 M | 1.42 M | 6 K | 6.5 K | 7 K | 7.4 K | 7.9 K | 8.3 K | 8.7 K | 2.61 M | 2.72 M | 3.14 M | 3.25 M | - | 3.45 M | 87.3 K | 125 K | 3 K | 3.8 M | 3.88 M | 3.96 M | 6.3 K | - | - | - | - | - | - | - | - | - | - | - | 27.2 K | 29.3 K | 31.4 K | 1.04 M | 35.6 K | 2.13 M | - | - | 1.8 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 3.64 M | 4.13 M | 4.44 M | 4.75 M | 5.05 M | 3.75 M | 4.16 M | 4.14 M | 11.9 M | 12 M | 12.1 M | 12.5 M | 12.7 M | 9.11 M | 8.73 M | 8.49 M | 8.25 M | 8.01 M | 4.14 M | 3.86 M | 3.59 M | 3.16 M | 2.9 M | 2.65 M | 2.4 M | 2.04 M | 1.73 M | 1.42 M | 1.14 M | 994 K | 2.17 M | 1.51 M | 909 K | 1.33 M | 3.42 M | 7.28 M | 10.9 M | 9.96 M | 7.86 M | 8.29 M | 9.91 M | 9.45 M | 7.86 M | 8.27 M | 3.94 M | 2.54 M | 11 M | 2.94 M | 3.07 M | 3.21 M | 7.85 M |
Total Liabilities |
9.52 M | 8.74 M | 7.78 M | 6.55 M | 8.18 M | 9.01 M | 9.03 M | 11.1 M | 12.7 M | 9.93 M | 10.6 M | 19.8 M | 18.3 M | 16.3 M | 15.5 M | 16 M | 11.8 M | 11.5 M | 11.4 M | 12.4 M | 11.3 M | 6.94 M | 5.83 M | 4.9 M | 5.03 M | 4.36 M | 3.98 M | 4.29 M | 3.04 M | 3.1 M | 3.29 M | 2.94 M | 2.6 M | 3.97 M | 3.61 M | 3.26 M | 4.61 M | 20.8 M | 18 M | 17.8 M | 16.2 M | 13.1 M | 12 M | 13.2 M | 12.4 M | 13.1 M | 10.8 M | 6.88 M | 6.93 M | 13.4 M | 5.16 M | 9.26 M | 8.75 M | 18.7 M |
Deferred Revenue |
2.47 M | 2.3 M | 1.76 M | 793 K | 714 K | 714 K | 712 K | 712 K | 1.24 M | 1.24 M | 1.42 M | 1.42 M | 1.42 M | 1.42 M | 1.24 M | 1.24 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-380 M | -367 M | -347 M | -340 M | -334 M | -327 M | -315 M | -305 M | -287 M | -268 M | -251 M | -240 M | -228 M | -220 M | -214 M | -208 M | -205 M | -202 M | -199 M | -193 M | -187 M | -181 M | -175 M | -168 M | -161 M | -157 M | -152 M | -149 M | -144 M | -142 M | -139 M | -137 M | -134 M | -132 M | -123 M | -121 M | -114 M | -84.5 M | -78.3 M | -77.2 M | -75.2 M | -70.6 M | -68.8 M | -68.9 M | -67.5 M | -70.6 M | -63.9 M | -58.6 M | -56.6 M | -67.7 M | -51.7 M | -47.2 M | -45 M | -42.6 M |
Total Assets |
102 M | 114 M | 131 M | 42.2 M | 15 M | 21.1 M | 29.7 M | 40.7 M | 58.7 M | 74.6 M | 90.5 M | 100 M | 104 M | 108 M | 109 M | 20.3 M | 6.17 M | 5.77 M | 5.33 M | 8.74 M | 12.9 M | 14 M | 7.52 M | 8.89 M | 8.26 M | 11.3 M | 14.2 M | 2.62 M | 2.44 M | 3.71 M | 5.88 M | 7.02 M | 8.76 M | 990 K | 2.01 M | 1.93 M | 1.74 M | 270 K | 259 K | 387 K | 765 K | 264 K | 329 K | 406 K | 432 K | 264 K | 326 K | 425 K | 645 K | 882 K | 400 K | 537 K | 1.68 M | 324 K |
Cash and Cash Equivalents |
84.2 M | 103 M | 127 M | 37.6 M | 9.62 M | 16.6 M | 25 M | 35.3 M | 52 M | 68.1 M | 83.7 M | 93.6 M | 97.8 M | 103 M | 104 M | 15.4 M | 1.55 M | 1.55 M | 1.06 M | 1.06 M | 4.07 M | 8.3 M | 6.29 M | 6.29 M | 7.83 M | 10.4 M | 13 M | 1.76 M | 1.63 M | 2.92 M | 4.37 M | 6.26 M | 8.5 M | 428 K | 1.16 M | 694 K | 121 K | 70 K | 13.2 K | - | 401 K | - | 20.7 K | 6.5 K | 89.8 K | 638 K | 24.2 K | 13.4 K | 31.7 K | 81 K | 166 K | 94.5 K | 94.5 K | 139 K |
Book Value |
93 M | 105 M | 123 M | 35.6 M | 6.85 M | 12.1 M | 20.7 M | 29.6 M | 46.1 M | 64.7 M | 80 M | 80.7 M | 85.6 M | 92 M | 93.8 M | 4.22 M | -5.61 M | -5.73 M | -6.09 M | -3.63 M | 1.63 M | 7.08 M | 1.69 M | 3.99 M | 3.22 M | 6.92 M | 10.3 M | -1.67 M | -607 K | 616 K | 2.59 M | 4.09 M | 6.16 M | -2.98 M | -1.6 M | -1.32 M | -2.87 M | -20.5 M | -17.8 M | -17.4 M | -15.4 M | -12.8 M | -11.7 M | -12.8 M | -11.9 M | -12.8 M | -10.5 M | -6.46 M | -6.28 M | -12.6 M | -4.76 M | -8.72 M | -7.07 M | -18.3 M |
Total Shareholders Equity |
93 M | 105 M | 123 M | 35.6 M | 6.85 M | 12.1 M | 20.7 M | 29.6 M | 46.1 M | 64.7 M | 80 M | 80.7 M | 85.6 M | 92 M | 93.8 M | 93.8 M | 4.22 M | -5.61 M | -6.09 M | -6.09 M | -3.63 M | 1.63 M | 1.69 M | 1.69 M | 3.99 M | 6.92 M | 10.3 M | -1.67 M | -607 K | 616 K | 2.59 M | 4.09 M | 6.16 M | -2.98 M | -1.6 M | -1.32 M | -2.87 M | -20.5 M | -17.8 M | -17.4 M | -15.4 M | -12.8 M | -11.7 M | -12.8 M | -11.9 M | -12.6 M | -10.5 M | -6.46 M | -6.28 M | -5.71 M | -4.76 M | -8.72 M | -7.07 M | -32.9 M |
All numbers in USD currency